Fenofibrate and Lisinopril drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Fenofibrate and Lisinopril together. This study is created by eHealthMe based on reports of 3,003 people who take Fenofibrate and Lisinopril from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on fenofibrate and lisinopril (the active ingredients of Fenofibrate and Lisinopril, respectively), and Fenofibrate and Lisinopril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. (latest outcomes from Fenofibrate 22,226 users)

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. (latest outcomes from Lisinopril 228,281 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Feb, 24, 2019

3,003 people who take Fenofibrate, Lisinopril are studied.


Number of reports submitted per year:

Fenofibrate and Lisinopril drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Ageusia (loss of taste functions of the tongue)
  2. Arthralgia (joint pain)
  3. Blood pressure decreased
  4. Blood pressure fluctuation
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Diabetic foot infection
  7. Diarrhoea
  8. Dizziness
  9. Dyspnoea (difficult or laboured respiration)
  10. Fatigue (feeling of tiredness)
1 - 6 months:
  1. Pain
  2. Pruritus (severe itching of the skin)
  3. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  4. Drug eruption (adverse drug reaction of the skin)
  5. Erythema annulare (redness of the skin with sign of inflammation or infection)
  6. Pigmentation disorder (disturbances of human skin colour)
  7. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  8. Somnolence (a state of near-sleep, a strong desire for sleep)
  9. Blood pressure fluctuation
  10. Cataract (clouding of the lens inside the eye)
6 - 12 months:
  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Aortic thrombosis (formation of a blood clot inside aorta)
  3. Blood urine present
  4. Fatigue (feeling of tiredness)
  5. Feeling cold
  6. Feeling jittery
  7. Haemorrhage (bleeding)
  8. Headache (pain in head)
  9. Hypoacusis (loss of hearing)
  10. Jaw disorder (jaw disease)
1 - 2 years:
  1. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Anaemia (lack of blood)
  4. Alanine aminotransferase increased
  5. Arthralgia (joint pain)
  6. Aspartate aminotransferase increased
  7. Cardiac failure congestive
  8. Chronic kidney disease
  9. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  10. Encephalopathy (functioning of the brain is affected by some agent or condition)
2 - 5 years:
  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Hypoglycaemia (deficiency of glucose in the bloodstream)
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Inappropriate antidiuretic hormone secretion
  5. Joint stiffness
  6. Limb discomfort (discomfort in leg)
  7. Muscle rigidity (muscle stiffness)
  8. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  9. Myalgia (muscle pain)
  10. Myocarditis (inflammation of heart muscle myocardium)
5 - 10 years:
  1. Depression
  2. Anxiety
  3. Chronic kidney disease
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Weight increased
  8. Abdominal pain
  9. Ageusia (loss of taste functions of the tongue)
  10. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
10+ years:
  1. Ageusia (loss of taste functions of the tongue)
  2. Dizziness
  3. Diabetic foot infection
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  6. Flatulence (flatus expelled through the anus)
  7. Lethargy (tiredness)
  8. Oropharyngeal pain
  9. Dyspnoea (difficult or laboured respiration)
  10. Acute myocardial infarction (acute heart attack)
not specified:
  1. Nausea (feeling of having an urge to vomit)
  2. Drug ineffective
  3. Diarrhoea
  4. Fatigue (feeling of tiredness)
  5. Pain
  6. Headache (pain in head)
  7. Vomiting
  8. Dyspnoea (difficult or laboured respiration)
  9. Weight decreased
  10. Blood glucose increased

Most common drug interactions by gender *:

female:
  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Asthenia (weakness)
  3. Pruritus (severe itching of the skin)
  4. Weight decreased
  5. Rash
  6. Dizziness
  7. Back pain
  8. Urinary tract infection
  9. Abdominal pain
  10. Depression
male:
  1. Drug ineffective
  2. Nausea (feeling of having an urge to vomit)
  3. Headache (pain in head)
  4. Vomiting
  5. Blood glucose increased
  6. Back pain
  7. Dizziness
  8. Pain in extremity
  9. Depression
  10. Renal failure (kidney dysfunction)

Most common drug interactions by age *:

0-1:

n/a

2-9:
  1. Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
  2. Influenza like illness
  3. Joint swelling
  4. Myositis (inflammation of the muscles)
10-19:
  1. Abdominal pain upper
  2. Drug ineffective
  3. Ear infection
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Nausea (feeling of having an urge to vomit)
  6. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Arthralgia (joint pain)
  9. Headache (pain in head)
  10. Injection site erythema (redness at injection site)
20-29:
  1. Abdominal pain
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  5. Hyperlipidaemia (presence of excess lipids in the blood)
  6. Pancreatitis acute (sudden inflammation of pancreas)
  7. Post procedural haemorrhage (post procedural bleeding)
  8. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  9. Acute myocardial infarction (acute heart attack)
  10. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
30-39:
  1. Weight decreased
  2. Pain
  3. Confusional state
  4. Abdominal pain
  5. Diarrhoea
  6. Dysphagia (condition in which swallowing is difficult or painful)
  7. Headache (pain in head)
  8. Anxiety
  9. Cervix disorder
  10. Constipation
40-49:
  1. Nausea (feeling of having an urge to vomit)
  2. Insomnia (sleeplessness)
  3. Pain in extremity
  4. Diarrhoea
  5. Vomiting
  6. Headache (pain in head)
  7. Fatigue (feeling of tiredness)
  8. Condition
  9. Drug ineffective
  10. Back pain
50-59:
  1. Pain
  2. Fall
  3. Pain in extremity
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Pancreatitis (inflammation of pancreas)
  6. Asthenia (weakness)
  7. Depression
  8. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  9. Dizziness
  10. Cough
60+:
  1. Nausea (feeling of having an urge to vomit)
  2. Fatigue (feeling of tiredness)
  3. Fall
  4. Pain in extremity
  5. Dizziness
  6. Insomnia (sleeplessness)
  7. Vomiting
  8. Weight decreased
  9. Rash
  10. Back pain

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and Lisinopril?


You are not alone:




Related publications that referenced our studies

Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Fenofibrate and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Lisinopril and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Fenofibrate and Lisinopril
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Fenofibrate and Lisinopril (49,017 reports studied)



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.